Optimizing an ethanol-based fixative for enhanced nucleic acid preservation in cervical samples using a central composite design approach
PLOS One · 26.06.2026 · 21 (6) · e0349088
DOI: 10.1371/journal.pone.0349088 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 26.06.2026. Verfasst von Ghazal Sedaghat Shayegan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Ethanol, Uterine Cervical Neoplasms, Fixatives, Cervix Uteri. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.
Abstract (Originalsprache)
Background
To accurately diagnose cervical cancer, high-quality genetic material (DNA and RNA) from clinical samples is crucial. Current preservation methods often have limitations, including poor RNA stability and safety concerns. This study aimed to develop an optimized ethanol-based fixative to preserve DNA and RNA in cervical samples under ambient conditions.
Methods
HeLa cells were fixed in ethanol-based fixatives containing polyhydric compounds (Sorbitol and polyethylene glycol [PEG]) and chelating agents. We used a central composite design (CCD) approach to evaluate the effects of pH, Sorbitol concentration, and PEG concentration on nucleic acid preservation. DNA and RNA quality were assessed using agarose gel electrophoresis, PCR, and real-time PCR. Cellular morphology was evaluated using Papanicolaou-stained slides. HPV genotyping of clinical samples was conducted using real-time PCR.
Results
The optimized fixative, developed in this study consisted of 40% ethanol, 4.3% Sorbitol, 1.2% PEG 8000, with a pH of 5.6. This new formula significantly improved DNA and RNA preservation compared to the commercial solution, PreservCyt. DNA showed high integrity and was successfully amplified in PCR test targeting HPV-18 oncogenes. RNA quality was confirmed through clear 28S and 18S rRNA bands and lower threshold cycle (Ct) values in qRT-PCR. HPV genotyping and morphological analysis revealed excellent preservation, enabling both molecular and cytological evaluations.
Conclusion
The new ethanol-based fixative represents a promising cost-effective and environmentally friendly solution for preserving nucleic acids and cellular morphology in cervical samples. Its good performance under ambient conditions suggests it may serve as an option for Human Papillomavirus (HPV) testing and cervical cancer prevention, particularly in places with limited resources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Genomics Department, Nilou Medical Laboratory, Tehran, Iran.
ORCID-Profile: Mohammad Hossein Modarressi
Förderung
- Tehran University of Medical Sciences and Health Services
Zitieren
APA
Sedaghat Shayegan, G., Salehipour, P., Najafi, A., & Modarressi, M. H. (2026). Optimizing an ethanol-based fixative for enhanced nucleic acid preservation in cervical samples using a central composite design approach. PLOS One, 21(6), e0349088. https://doi.org/10.1371/journal.pone.0349088
Vancouver
Sedaghat Shayegan G, Salehipour P, Najafi A, Modarressi MH. Optimizing an ethanol-based fixative for enhanced nucleic acid preservation in cervical samples using a central composite design approach. PLOS One. 2026;21(6):e0349088. doi:10.1371/journal.pone.0349088
BibTeX
@article{SedaghatShayegan2026,
author = {Sedaghat Shayegan, Ghazal and Salehipour, Pouya and Najafi, Ali and Modarressi, Mohammad Hossein},
title = {Optimizing an ethanol-based fixative for enhanced nucleic acid preservation in cervical samples using a central composite design approach},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0349088},
doi = {10.1371/journal.pone.0349088}
}
EUVIMED